Christina Jean Lindler, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4037 Budd Rd, New Smyrna, FL 32168 Phone: 386-214-2739 |
News Archive
Reports in the UK suggest that almost 400,000 youngsters aged between 5 and 19 are being treated with Ritalin and similar drugs for attention deficit hyperactivity disorder, or ADHD, regardless of fears about the drugs' serious side-effects such as cardiovascular disorders, hallucinations and even suicidal thoughts.
Varian, Inc. announced today that Bruker Corporation and Agilent Technologies, Inc. have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian. As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its AmicusĀ® blood cell separator.
In a major advance for schizophrenia research, an international team of scientists led by the University of California, San Diego School of Medicine and involving Trinity College Dublin researchers has identified a gene mutation strongly linked to schizophrenia that may be an important new target for the development of drug therapies.
› Verified 1 days ago